Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 20

Publication Record

Connections

Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.
Osgood MJ, Sexton K, Voskresensky I, Hocking K, Song J, Komalavilas P, Brophy C, Cheung-Flynn J
(2016) J Vasc Surg 64: 471-478
MeSH Terms: Animals, Benzenesulfonates, Cell Line, Cell Movement, Cell Proliferation, Coloring Agents, Humans, Hyperplasia, Jugular Veins, Models, Animal, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, Neointima, Organ Culture Techniques, Purinergic P2X Receptor Antagonists, Rabbits, Rats, Receptors, Purinergic P2X7, Saphenous Vein, Signal Transduction, Time Factors, Tissue and Organ Harvesting
Added March 3, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury.
Hocking KM, Luo W, Li FD, Komalavilas P, Brophy C, Cheung-Flynn J
(2016) J Vasc Surg 64: 210-8
MeSH Terms: Animals, Aorta, Benzenesulfonates, Calcium Signaling, Cells, Cultured, Coloring Agents, Cytoprotection, Female, Human Umbilical Vein Endothelial Cells, Humans, Hyperplasia, In Vitro Techniques, Male, Neointima, Organ Culture Techniques, Purinergic P2X Receptor Antagonists, Rats, Sprague-Dawley, Receptors, Purinergic P2X7, Saphenous Vein, Swine, Vascular Grafting, Vascular System Injuries, Vasoconstriction
Added March 9, 2015
0 Communities
2 Members
0 Resources
23 MeSH Terms
Brilliant blue FCF as an alternative dye for saphenous vein graft marking: effect on conduit function.
Voskresensky IV, Wise ES, Hocking KM, Li FD, Osgood MJ, Komalavilas P, Brophy C, Cheung-Flynn J
(2014) JAMA Surg 149: 1176-81
MeSH Terms: Analysis of Variance, Animals, Benzenesulfonates, Coloring Agents, Endothelium, Vascular, Graft Survival, Humans, Muscle Contraction, Muscle, Smooth, Vascular, Organ Culture Techniques, Primary Graft Dysfunction, Rats, Rats, Sprague-Dawley, Saphenous Vein, Vena Cava, Inferior
Added March 9, 2015
0 Communities
2 Members
0 Resources
15 MeSH Terms
Blocking the P2X7 receptor improves outcomes after axonal fusion.
Rodriguez-Feo CL, Sexton KW, Boyer RB, Pollins AC, Cardwell NL, Nanney LB, Shack RB, Mikesh MA, McGill CH, Driscoll CW, Bittner GD, Thayer WP
(2013) J Surg Res 184: 705-13
MeSH Terms: Action Potentials, Adenosine Triphosphate, Animals, Axons, Benzenesulfonates, Coloring Agents, Drug Carriers, Male, Motor Activity, Nerve Regeneration, Neurosurgical Procedures, Platelet Aggregation Inhibitors, Polyethylene Glycols, Purinergic P2X Receptor Antagonists, Rats, Rats, Sprague-Dawley, Receptors, Purinergic P2X7, Sciatic Neuropathy, Wallerian Degeneration, Wound Healing
Added July 9, 2013
0 Communities
1 Members
0 Resources
20 MeSH Terms
Cardiac side effects of anticancer treatments: new mechanistic insights.
Geisberg C, Pentassuglia L, Sawyer DB
(2012) Curr Heart Fail Rep 9: 211-8
MeSH Terms: Anthracyclines, Antibiotics, Antineoplastic, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Benzenesulfonates, Daunorubicin, Doxorubicin, Heart Failure, Humans, Indoles, Myocardial Contraction, Myocytes, Cardiac, Niacinamide, Phenylurea Compounds, Pyridines, Pyrroles, Sorafenib, Sunitinib, Trastuzumab
Added March 5, 2014
1 Communities
1 Members
0 Resources
19 MeSH Terms
Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenib.
Khandani AH, Cowey CL, Moore DT, Gohil H, Rathmell WK
(2012) Nucl Med Commun 33: 967-73
MeSH Terms: Adult, Aged, Aged, 80 and over, Benzenesulfonates, Biological Transport, Carcinoma, Renal Cell, Feasibility Studies, Female, Fluorodeoxyglucose F18, Humans, Kidney Neoplasms, Male, Middle Aged, Multimodal Imaging, Neoadjuvant Therapy, Niacinamide, Phenylurea Compounds, Positron-Emission Tomography, Pyridines, Safety, Sorafenib, Survival Analysis, Tomography, X-Ray Computed, Treatment Outcome, Young Adult
Added October 17, 2015
0 Communities
1 Members
0 Resources
25 MeSH Terms
Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumors.
Rosen LS, Puzanov I, Friberg G, Chan E, Hwang YC, Deng H, Gilbert J, Mahalingam D, McCaffery I, Michael SA, Mita AC, Mita MM, Mulay M, Shubhakar P, Zhu M, Sarantopoulos J
(2012) Clin Cancer Res 18: 3414-27
MeSH Terms: Adult, Aged, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Benzenesulfonates, Biomarkers, Tumor, Deoxycytidine, Erlotinib Hydrochloride, Female, Humans, Male, Middle Aged, Neoplasms, Niacinamide, Panitumumab, Phenylurea Compounds, Pyridines, Quinazolines, Receptor, IGF Type 1, Sorafenib
Added March 5, 2014
0 Communities
1 Members
0 Resources
21 MeSH Terms
Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438).
Margolin KA, Moon J, Flaherty LE, Lao CD, Akerley WL, Othus M, Sosman JA, Kirkwood JM, Sondak VK
(2012) Clin Cancer Res 18: 1129-37
MeSH Terms: Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Benzenesulfonates, Female, Humans, Male, Melanoma, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Niacinamide, Phenylurea Compounds, Pyridines, Quinolones, Sirolimus, Sorafenib, Survival Analysis, Treatment Outcome
Added March 20, 2014
0 Communities
1 Members
0 Resources
20 MeSH Terms
Reversible cardiomyopathy associated with sunitinib and sorafenib.
Uraizee I, Cheng S, Moslehi J
(2011) N Engl J Med 365: 1649-50
MeSH Terms: Aged, Antineoplastic Agents, Benzenesulfonates, Cardiomyopathies, Female, Humans, Indoles, Male, Middle Aged, Niacinamide, Phenylurea Compounds, Protein-Tyrosine Kinases, Pyridines, Pyrroles, Sorafenib, Sunitinib, Vascular Endothelial Growth Factor A
Added March 4, 2015
0 Communities
1 Members
0 Resources
17 MeSH Terms
Amended safety assessment of dodecylbenzenesulfonate, decylbenzenesulfonate, and tridecylbenzenesulfonate salts as used in cosmetics.
Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA
(2010) Int J Toxicol 29: 288S-305
MeSH Terms: Alkanesulfonic Acids, Animals, Benzenesulfonates, Chemical Phenomena, Consumer Product Safety, Cosmetics, Detergents, Dose-Response Relationship, Drug, Humans, Irritants, Mutagenicity Tests, Rabbits, Skin, Surface-Active Agents, Toxicity Tests, Acute, Toxicity Tests, Chronic
Added March 20, 2014
0 Communities
1 Members
0 Resources
16 MeSH Terms